Association between MRI-derived hepatic fat fraction and blood pressure in participants without history of cardiovascular disease

Objectives: We assessed whether liver fat content, as determined by MRI, correlates with blood pressure (BP), a major vascular risk factor, in individuals from the general population without history of stroke and coronary or peripheral artery disease. Methods: Cross-sectional data from 384 participants (161 women; aged 39–73 years) of a MRI substudy of the KORA FF4 survey were used. Hepatic fat fraction (HFF) was measured in the left and right lobe of the liver using single voxel multiecho 1H-spectroscopy and at the level of the portal vein using a multiecho Dixon-sequence. Associations of HFF with SBP and DBP as well as hypertension were assessed by right censored normal regression (accounting for antihypertensive treatment) and by logistic regression, respectively. Results: High levels of HFF measured on the level of the portal vein (90th percentile, 21.8%), compared with low HFF levels (10th percentile, 1.7%), were associated with higher SBP (131 vs. 122 mmHg; overall P = 0.001), higher DBP (82 vs. 76 mmHg, P < 0.001) and with higher odds of hypertension [odds ratio (OR) = 2.16, P = 0.025]. A level of 5.13% (54th percentile) was identified as optimal HFF cut-off for the prediction of hypertension (OR = 2.00, P = 0.015). Alcohol consumption emerged as an effect modifier for the association between HFF and hypertension (nonalcohol drinker: OR = 3.76, P = 0.025; alcohol drinker: OR = 1.59, P = 0.165). Conclusion: MRI-derived subclinical HFF is associated with SBP and DBP as well as with hypertension in participants from the general population without history of cardiovascular disease.

[1]  W. Rathmann,et al.  Subclinical Disease Burden as Assessed by Whole-Body MRI in Subjects With Prediabetes, Subjects With Diabetes, and Normal Control Subjects From the General Population: The KORA-MRI Study , 2016, Diabetes.

[2]  C. Fox,et al.  Hepatic steatosis and cardiovascular disease outcomes: An analysis of the Framingham Heart Study. , 2015, Journal of hepatology.

[3]  Múltipla ver em Notas.,et al.  Effects of diabetes definition on global surveillance of diabetes prevalence and diagnosis: a pooled analysis of 96 population-based studies with 331 288 participants , 2015, The lancet. Diabetes & endocrinology.

[4]  M. Blaha,et al.  Blood pressure is associated with the presence and severity of nonalcoholic fatty liver disease across the spectrum of cardiometabolic risk , 2015, Journal of hypertension.

[5]  Tao Zhang,et al.  Metabolic syndrome and its components as predictors of nonalcoholic fatty liver disease in a northern urban Han Chinese population: a prospective cohort study. , 2015, Atherosclerosis.

[6]  U. Nöthlings,et al.  Association of a lifestyle index with MRI-determined liver fat content in a general population study , 2015, Journal of Epidemiology and Community Health.

[7]  Shuiping Zhao,et al.  Nonalcoholic fatty liver disease as a potential risk factor of cardiovascular disease , 2015, European journal of gastroenterology & hepatology.

[8]  D. Lawlor,et al.  The association of nonalcoholic fatty liver disease with central and peripheral blood pressure in adolescence: findings from a cross-sectional study , 2015, Journal of hypertension.

[9]  A. Federico,et al.  Non alcoholic fatty liver: epidemiology and natural history. , 2015, Reviews on recent clinical trials.

[10]  Y. Cho,et al.  Clinical association between non‐alcoholic fatty liver disease and the development of hypertension , 2014, Journal of gastroenterology and hepatology.

[11]  Berthold Kiefer,et al.  Liver fat quantification using a multi‐step adaptive fitting approach with multi‐echo GRE imaging , 2014, Magnetic resonance in medicine.

[12]  J. Stoker,et al.  Measuring liver triglyceride content in mice: non-invasive magnetic resonance methods as an alternative to histopathology , 2014, Magnetic Resonance Materials in Physics, Biology and Medicine.

[13]  Philippe Pibarot,et al.  Visceral/epicardial adiposity in nonobese and apparently healthy young adults: association with the cardiometabolic profile. , 2014, Atherosclerosis.

[14]  Ming-Chih Ho,et al.  Quantification of hepatic steatosis: A comparison of the accuracy among multiple magnetic resonance techniques , 2014, Journal of gastroenterology and hepatology.

[15]  M. Al-mallah,et al.  A systematic review: burden and severity of subclinical cardiovascular disease among those with nonalcoholic fatty liver; should we care? , 2013, Atherosclerosis.

[16]  S. Bertrais,et al.  MRI measurement of liver fat content predicts the metabolic syndrome. , 2013, Diabetes & metabolism.

[17]  J. Tuomilehto,et al.  Fatty liver score and 15-year incidence of type 2 diabetes , 2013, Hepatology International.

[18]  W. Rathmann,et al.  Vasoregulatory peptides pro-endothelin-1 and pro-adrenomedullin are associated with metabolic syndrome in the population-based KORA F4 study. , 2012, European journal of endocrinology.

[19]  Y. Kesäniemi,et al.  High ambulatory blood pressure values associated with non-alcoholic fatty liver in middle-aged adults , 2012, Journal of hypertension.

[20]  Henry Völzke,et al.  Multicausality in fatty liver disease: is there a rationale to distinguish between alcoholic and non-alcoholic origin? , 2012, World journal of gastroenterology.

[21]  Henry Völzke,et al.  The association between fatty liver disease and blood pressure in a population-based cohort study. , 2012, Journal of hypertension.

[22]  Christopher D Byrne,et al.  Non-alcoholic fatty liver disease: a new and important cardiovascular risk factor? , 2012, European heart journal.

[23]  Sander Greenland,et al.  A Procedure to Tabulate and Plot Results after Flexible Modeling of a Quantitative Covariate , 2011 .

[24]  Henry Völzke,et al.  The association between fatty liver disease and blood pressure in a population-based prospective longitudinal study , 2010, Journal of hypertension.

[25]  J. Stoker,et al.  The diagnostic accuracy of US, CT, MRI and 1H-MRS for the evaluation of hepatic steatosis compared with liver biopsy: a meta-analysis , 2010, European Radiology.

[26]  François Mariotti,et al.  Dose‐response analyses using restricted cubic spline functions in public health research , 2010, Statistics in medicine.

[27]  R. Holle,et al.  Incidence of Type 2 diabetes in the elderly German population and the effect of clinical and lifestyle risk factors: KORA S4/F4 cohort study , 2009, Diabetic medicine : a journal of the British Diabetic Association.

[28]  F. Schick,et al.  Non-invasive assessment and quantification of liver steatosis by ultrasound, computed tomography and magnetic resonance. , 2009, Journal of hepatology.

[29]  Xiaoping Hu,et al.  Measurement of hepatic lipid: high-speed T2-corrected multiecho acquisition at 1H MR spectroscopy--a rapid and accurate technique. , 2009, Radiology.

[30]  Benjamin M Yeh,et al.  Evaluation of diffuse liver steatosis by ultrasound, computed tomography, and magnetic resonance imaging: which modality is best? , 2009, Clinical imaging.

[31]  G. Radaelli,et al.  MRI in Identifying Hepatic Steatosis in Obese Children and Relation to Ultrasonography and Metabolic Findings , 2008, Journal of pediatric gastroenterology and nutrition.

[32]  Norbert Stefan,et al.  Causes and metabolic consequences of Fatty liver. , 2008, Endocrine reviews.

[33]  J. Lüdemann,et al.  Regional disparities of hypertension prevalence and management within Germany , 2006, Journal of hypertension.

[34]  Nuala A Sheehan,et al.  Adjusting for treatment effects in studies of quantitative traits: antihypertensive therapy and systolic blood pressure , 2005, Statistics in medicine.

[35]  J. Whitworth,et al.  2003 World Health Organization (WHO)/International Society of Hypertension (ISH) statement on management of hypertension , 2003, Journal of hypertension.

[36]  L Wood,et al.  Adipose tissue tumor necrosis factor and interleukin-6 expression in human obesity and insulin resistance. , 2001, American journal of physiology. Endocrinology and metabolism.

[37]  A. Peters,et al.  Feasibility of a three-step magnetic resonance imaging approach for the assessment of hepatic steatosis in an asymptomatic study population , 2015, European Radiology.

[38]  Gretchen A. Stevens,et al.  Effects of diabetes definition on global surveillance of diabetes prevalence and diagnosis: a pooled analysis of 96 population-based studies with 331 288 participants , 2015 .